Work

Abstract LB011: Combining CBP/p300 and PARP inhibitors to enhance anti-tumor efficacy in lethal prostate cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-lb011

Authors: Orly Richter, Sumaira Sardar, Lakshmi Ravindranath, Christopher McNair, Xiaofeng Su, Adam Sharp, Johann de Bono, Kris Frese, Karen Knudsen, Ayesha Shafi

Institutions: Uniformed Services University of the Health Sciences, Thomas Jefferson University, Sidney Kimmel Cancer Center, Institute of Cancer Research, CellCentric (United Kingdom), American Cancer Society

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821694

Cites:

Cited by:

Related to: 10